Praxis Precision Medicines (PRAX) Shares Outstanding (Diluted Average) (2020 - 2026)

Praxis Precision Medicines' Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $28.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 37.18% year-over-year to $28.9 million; the TTM figure through Mar 2026 stood at $28.9 million (up 37.18% YoY), while the FY2025 annual figure was $22.5 million, up 25.68% from the prior year.
• Shares Outstanding (Diluted Average) was $28.9 million for Q1 2026 at Praxis Precision Medicines, up from $22.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $45.8 million in Q3 2022 to a low of $3.1 million in Q4 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $20.4 million across 5 years, with a median of $18.8 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) plunged 92.76% in 2022, then jumped 359.38% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $3.1 million in 2022, then surged by 114.58% to $6.6 million in 2023, then surged by 171.55% to $17.9 million in 2024, then rose by 25.68% to $22.5 million in 2025, then increased by 28.34% to $28.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $28.9 million (Q1 2026), $22.5 million (Q4 2025), and $21.5 million (Q3 2025), per Business Quant data.